Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 8 studies | 55% ± 30% | |
goblet cell | 6 studies | 31% ± 8% | |
paneth cell | 4 studies | 81% ± 8% | |
epithelial cell | 3 studies | 43% ± 33% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 5 studies | 29% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 87% | 6801.13 | 845 / 966 | 71% | 68.90 | 375 / 527 |
pancreas | 87% | 13.96 | 285 / 328 | 20% | 11.94 | 35 / 178 |
stomach | 28% | 4.55 | 102 / 359 | 49% | 45.92 | 141 / 286 |
bladder | 29% | 1.38 | 6 / 21 | 40% | 36.62 | 202 / 504 |
spleen | 66% | 5.22 | 159 / 241 | 0% | 0 | 0 / 0 |
lung | 59% | 7.08 | 343 / 578 | 6% | 1.70 | 71 / 1155 |
liver | 36% | 2.38 | 82 / 226 | 18% | 5.39 | 75 / 406 |
adrenal gland | 53% | 3.50 | 137 / 258 | 1% | 0.05 | 2 / 230 |
thymus | 33% | 2.36 | 214 / 653 | 0% | 0.08 | 2 / 605 |
esophagus | 16% | 4.11 | 232 / 1445 | 14% | 4.60 | 25 / 183 |
prostate | 25% | 2.42 | 62 / 245 | 0% | 0.88 | 1 / 502 |
uterus | 20% | 2.61 | 34 / 170 | 4% | 2.85 | 20 / 459 |
breast | 23% | 15.03 | 107 / 459 | 0% | 0.02 | 3 / 1118 |
ovary | 22% | 1.76 | 39 / 180 | 1% | 0.19 | 3 / 430 |
heart | 17% | 0.93 | 149 / 861 | 0% | 0 | 0 / 0 |
adipose | 17% | 1.85 | 202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 16% | 1.06 | 209 / 1335 | 0% | 0 | 0 / 0 |
muscle | 14% | 0.80 | 115 / 803 | 0% | 0 | 0 / 0 |
skin | 13% | 1.07 | 244 / 1809 | 0% | 0 | 0 / 472 |
kidney | 13% | 0.60 | 12 / 89 | 0% | 0 | 0 / 901 |
peripheral blood | 12% | 0.71 | 113 / 929 | 0% | 0 | 0 / 0 |
brain | 9% | 0.50 | 238 / 2642 | 1% | 0.25 | 4 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0005576 | Cellular component | extracellular region |
GO_0005179 | Molecular function | hormone activity |
GO_0030250 | Molecular function | guanylate cyclase activator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GUCA2A |
Protein name | Guanylin (Guanylate cyclase activator 2A) (Guanylate cyclase-activating protein 1) (Guanylate cyclase-activating protein I) (GCAP-I) [Cleaved into: HMW-guanylin; Guanylin] |
Synonyms | GUCA2 |
Description | FUNCTION: Endogenous activator of intestinal guanylate cyclase. It stimulates this enzyme through the same receptor binding region as the heat-stable enterotoxins. |
Accessions | ENST00000357001.3 Q02747 |